Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second Look Laparoscopy vs Standard Follow-up in Mucinous Colorectal Cancer
NCT01628211Phase 2Unknown
- Sponsor
- National Cancer Institute
- Start
- Apr 2012
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in colorectal cancer (CRC), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01628211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628211.